Amount Raised
$17.5 Million
Round Type
Series C
Description
Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from Cercano Management as well as from existing investors, including JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech. This investment brings the company’s total funding to over $40 million.
Quick answer
Genetesis raised $17.5 Million in a Series C round, dated October 6, 2022. Genetesis is based in Mason, Texas, United States.
- How much did Genetesis raise?
- Genetesis raised $17.5 Million in a Series C round on October 6, 2022.
- What does Genetesis do?
- Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
- Where is Genetesis based and how big is it?
- Genetesis is based in Mason, Texas, United States.
Source: Fundz verified event record.
Who to call at Genetesis, and when
A new round usually means Genetesis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Genetesis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genetesis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genetesis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genetesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Genetesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.